Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05617313 |
|---|---|
| Brief Title: | Study of GT103 in Combination With Pembrolizumab in Refractory, Metastatic Non-Small Cell Lung Cancer |
| First Submitted : | November 7, 2022 |
| First Submitted that Met QC Criteria : | November 14, 2022 |
| First Posted : | November 15, 2022 |
| Last Update Submitted that Met QC Criteria : | February 29, 2024 |
| Last Update Posted : | March 4, 2024 |